BCBA/CVS (BCBA/CVS)

Buenos Aires Stock Exchange: BCBA/CVS · ARS

ARS 10,000

-279.61 (-2.7%)· Recorded snapshot

Market cap	179.3T
Revenue (ttm)	611.3T
Net income (ttm)	7.2T
EPS (ttm)	ARS 391
P/E (trailing)	25.6x
P/E (forward)	11.1x
Dividend	ARS 188 (1.88%)
Volume	10,393

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 611.3T
Net income (ttm): 7.2T
EPS (ttm): ARS 391
P/E (trailing): 25.6x
P/E (forward): 11.1x
Market cap: 179.3T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.1

P25 n/aP50 n/aP75 n/a

Trailing P/E25.6

P25 n/aP50 n/aP75 n/a

ROE6.2

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/CVS indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-04
Employees	300,000
Employees change	0
Employees growth	0%
Enterprise value	ARS 275.5T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1963
Industry	Healthcare Plans
Is primary listing	No
ISIN number	AR0107022060
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Market cap	ARS 179.3T
Next earnings date	2026-11-04
Price	ARS 10,000.00
Price currency	ARS
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-27
Symbol	bcba/CVS
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	23.26x
Average P/E ratio (3Y)	35.75x
Average P/E ratio (5Y)	30.59x
Earnings yield	3.91%
EV/Earnings	38.03x
EV/EBIT	14.73x
EV/EBITDA	9.09x
EV/FCF	15.81x
EV/Sales	0.43x
FCF / EV yield	6.32%
FCF yield	9.72%
Forward P/E	11.12x
Graham number	7747.88839
Graham upside	-22.52%
Lynch fair value	ARS 2,020.44
Lynch upside	-79.8%
P/(FCF - SBC) ratio	10.96x
P/(OCF - SBC) ratio	8.6x
P/B ratio	1.51x
P/E ratio	25.55x
P/FCF ratio	10.29x
P/OCF ratio	8.19x
P/S ratio	0.29x
Price/EBITDA ratio	7.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.95%
EBITDA margin	4.04%
Effective tax rate	15.59%
FCF margin	2.74%
Gross margin	13.64%
Operating margin	2.95%
Pretax margin	1.4%
Profit margin	1.19%
Profit per employee	ARS 27.9M
Profitable quarters	3
Profitable years	7
Revenue per employee	ARS 2.4B
ROA	2.97%
ROA (5Y)	3.25%
ROCE	7.29%
ROE	6.21%
ROE (5Y)	7.3%
ROIC	7.17%
ROIC (5Y)	6.76%
SBC / revenue	0.17%
Tax / revenue	0.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	6.3%
EPS growth (Q)	188.75%
EPS growth (QoQ)	0.43%
EPS growth 10Y	-1.29%
EPS growth 3Y	18.83%
EPS growth 5Y	-6.92%
EPS growth quarters	3
EPS growth years	0
FCF growth	145.98%
FCF growth (Q)	338.3%
FCF growth (QoQ)	66.29%
FCF growth 3Y	-12.7%
FCF growth 5Y	0.24%
Gross profit growth	10.11%
Gross profit growth (Q)	15.28%
Gross profit growth 3Y	1.97%
Gross profit growth 5Y	3.1%
Net income growth	7.92%
Net income growth (Q)	191.77%
Net income growth (QoQ)	1.22%
Net income growth 3Y	18.15%
Net income growth 5Y	-7.45%
Net income growth quarters	3
Net income growth years	0
OCF growth	95.3%
OCF growth (Q)	234.48%
OCF growth (QoQ)	49.33%
OCF growth 10Y	4.54%
OCF growth 3Y	-10.36%
OCF growth 5Y	0.83%
Operating income growth	30.17%
Operating income growth (Q)	47.59%
Operating income growth 3Y	-5.64%
Operating income growth 5Y	-1.43%
Revenue growth	7.37%
Revenue growth (Q)	7.14%
Revenue growth (QoQ)	5.61%
Revenue growth 10Y	9.49%
Revenue growth 3Y	6.87%
Revenue growth 5Y	8.28%
Revenue growth quarters	53
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -4.5T
Depreciation and amortization	ARS 7T
EBIT	ARS 18T
EBITDA	ARS 24.7T
EPS	ARS 391.37
Financing cash flow	ARS -12.5T
Free cash flow	ARS 17.4T
Free cash flow minus SBC	ARS 16.4T
Gross profit	ARS 83.4T
Income taxes	ARS 1.3T
Investing cash flow	ARS -10.1T
Net borrowing	ARS -8T
Net cash flow	ARS -723B
Net income	ARS 7.2T
Operating cash flow minus SBC	ARS 20.8T
Operating income	ARS 18T
Revenue	ARS 611.3T
Stock-based compensation	ARS 1.1T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.43
Book value per share	ARS 92,393.20
Debt / EBITDA	3.87
Debt / equity	0.96
Debt / FCF	6.49
Goodwill	ARS 131.5T
Interest coverage	3.92
Long-term assets	ARS 260.1T
Long-term liabilities	ARS 123.7T
Net cash (debt)	ARS -92.4T
Net cash / market cap	-51.52%
Net debt / EBITDA	3.74
Net debt / equity	0.78
Net debt / FCF	5.3
Piotroski F-Score	7
Property, plant and equipment	ARS 42.5T
Shareholders' equity	ARS 118.4T
Tangible book value	ARS -45.1T
Tangible book value per share	ARS -35,263.87
Total assets	ARS 376T
Total cash	ARS 20.7T
Total debt	ARS 113T
Total liabilities	ARS 257.6T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.61
Current assets	ARS 115.9T
Current liabilities	ARS 133.9T
Current ratio	0.87
Inventory turnover	20.32
Net working capital	ARS -32.3T
Quick ratio	0.62
Working capital	ARS -17.3T
Working capital turnover	-40,474.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.19%
Dividend growth	36.71%
Dividend growth years	1
Dividend payment date	2026-11-02
Dividend payment years	3
Dividend payout frequency	Quarterly
Dividend per share	ARS 187.75
Dividend yield	1.88%
Ex-dividend date	2026-10-22
Last dividend	ARS 67.68
Payout ratio	69.86%
Shareholder yield	0.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 9,492.27
1D price change	-2.72%
1M price change	3.84%
1M total return	4.54%
1W price change	-0.3%
1W total return	0.37%
1Y price change	17.1%
1Y return CAGR	19.51%
1Y total return	19.49%
20-day SMA	ARS 9,728.00
200-day SMA	ARS 9,049.35
3M price change	-12.36%
3M total return	-11.77%
50-day SMA	ARS 9,821.90
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 12,000.00
52-week high date	2026-07-01
52-week low	ARS 6,585.00
52-week low date	2026-03-26
6M price change	30.89%
6M total return	32.25%
All-time high	ARS 12,000.00
All-time high date	2026-07-01
All-time low	ARS 3,390.00
All-time low date	2024-12-20
Average true range (ATR)	ARS 273.09
Average volume	12.9K
Change from 52-week high	-16.67%
Change from 52-week low	51.86%
Change from all-time high	-16.67%
Change from all-time low	194.99%
Change from open	-3.29%
Day's gap	0.58%
Dollar volume	ARS 103.9M
High price	ARS 10,390.00
Low price	ARS 10,000.00
Monthly RSI	66.34
Open price	ARS 10,340.00
Position in 52-week range	0%
Previous close	ARS 10,280.00
Price vs 150-day SMA	5.35%
Price vs 20-day SMA	2.8%
Price vs 200-day SMA	10.51%
Price vs 50-day SMA	1.81%
Relative volume	0.8
RSI	53.95
Sharpe ratio	0.7
Sortino ratio	1.18
Volume	10.4K
Weekly RSI	54.19
YTD price change	34.59%
YTD total return	37.34%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.3B
Shares change (QoQ)	0.63%
Shares change (YoY)	1.19%
Shares held by insiders	0.09%
Shares held by institutions	90.42%
Short ratio	2 days

Deeper analysis on BCBA/CVS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/CVS report

Is a complete BCBA/CVS research report available?

No complete published report is available for bcba/CVS (BCBA/CVS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/CVS (BCBA/CVS)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/CVS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/CVS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/CVS

Frequently asked questions